Last updated: April 11, 2024
Sponsor: Assistance Publique - Hôpitaux de Paris
Overall Status: Active - Recruiting
Phase
N/A
Condition
Holoprosencephaly
Treatment
Individualisation of uronephrological complications risk factors
Clinical Study ID
NCT05718440
APHP221008
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- men and women over 18 years old with spinal dysraphism,
- urinary and/or bowel and/or sexual dysfunction,
- evaluated in a one day consultation in a neuro-urology department.
- Informed consent is required from the patient or his tutor/curator if he is underlegal protection
Exclusion
Exclusion Criteria:
- language barrier with non-understanding of French language,
- other neurologic pathologies except syringomyelia, Chiari malformation orhydrocephalus who are often associated to spinal dysraphism.
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Individualisation of uronephrological complications risk factors
Phase:
Study Start date:
November 06, 2023
Estimated Completion Date:
November 30, 2028
Study Description
Connect with a study center
Tenon hospital
Paris, 75020
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.